Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Spark Therap (NQ: ONCE )

N/A USD UNCHANGED
Last Price Updated: 12:31 PM EST, Dec 17, 2019 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Spark Therap

< Previous 1 2 3 4 5 6 Next >
Spark Therapeutics Wins Prix Galien USA Award for LUXTURNA® (voretigene neparvovec-rzyl) as Best Biotechnology Product
From GlobeNewswire News Releases
Paralympic Skier Danelle Umstead Teams Up with Spark Therapeutics to Help People Living with Inherited Retinal Diseases (IRDs) Access Genetic Testing
From GlobeNewswire News Releases
Spark Therapeutics Announces Change of Location for Annual Meeting of Stockholders
From GlobeNewswire News Releases
New Gene Therapies Hold Out Promise for Patients
NetworkNewsWire Editorial Coverage 
From PR Newswire
Spark Therapeutics Announces Sponsorship of Believe Limited’s First-Ever Science Fair for the Hemophilia Community at 2019 National Hemophilia Foundation’s Bleeding Disorders Conference
The Science Fair™ aims to engage and educate patients, families and caregivers affected by bleeding 
From GlobeNewswire News Releases
Spark Therapeutics (ONCE) Merger Class Action Lawsuit: Halper Sadeh LLP Announces Filing of Shareholder Class Action Lawsuit Against Spark Therapeutics, Inc. Concerning Its Proposed Merger With Roche
Halper Sadeh LLP, a global investor rights law firm, announces the filing of a shareholder class action lawsuit against Spark Therapeutics, Inc. (“Spark” or the “Company”) (NASDAQ: ONCE) in connection... 
From GlobeNewswire News Releases
Recent Analysis Shows A. O. Smith, Plains Group Holdings, The Hackett Group, Ryder System, MUELLER WATER PRODUCTS, and Spark Therapeutics Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of A. O. Smith Corporation... 
From GlobeNewswire News Releases
Rigrodsky & Long, P.A. Files Class Action Suit Against Spark Therapeutics, Inc.
Rigrodsky & Long, P.A.: 
From GlobeNewswire News Releases
MERGER ALERT – CMTA and ONCE: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
The following statement is being issued by Levi & Korsinsky, LLP: 
From GlobeNewswire News Releases
AsclepiX Therapeutics, Inc. Strengthens Board of Directors, Welcomes Steven Altschuler, MD
From ACCESSWIRE
Lifshitz & Miller LLP Announces Investigation of AVEO Pharmaceuticals, Inc., CenturyLink, Inc., Inogen, Inc., Mattel, Inc., Spark Therapeutics, Inc., Stamps.com, Inc., Syneos Health, Inc., and Weight
From PR Newswire
NASDAQ:ONCE Investor Alert: Lawsuit Filed Against the Acquisition of Spark Therapeutics, Inc.
San Diego, CA -- (SBWIRE) -- 03/18/2019 -- An investor, who currently holds shares of Spark Therapeutics, Inc. (NASDAQ: ONCE), filed a lawsuit against the takeover of Spark Therapeutics, Inc. 
From SBWire - Latest Press Releases
SPARK THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Rigrodsky & Long, P.A.: 
From GlobeNewswire News Releases
Making Profits, Saving Lives With Gene Therapy
NetworkNewsWire Editorial Coverage 
From PR Newswire
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Spark Therapeutics, Inc. - ONCE
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Spark Therapeutics,... 
From PR Newswire
NASDAQ:ONCE Shareholder Alert: Investigation of Takeover of Spark Therapeutics, Inc.
San Diego, CA -- (SBWIRE) -- 03/06/2019 -- An investigation on behalf of investors, who currently hold shares of Spark Therapeutics, Inc. (NASDAQ: ONCE), was announced concerning whether the takeover... 
From SBWire - Latest Press Releases
MERGER ALERT – LABL and ONCE: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
The following statement is being issued by Levi & Korsinsky, LLP: 
From GlobeNewswire News Releases
MERGER ALERT – LABL, CMTA and ONCE: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
The following statement is being issued by Levi & Korsinsky, LLP: 
From GlobeNewswire News Releases
SPARK THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
SPARK THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 
From Business Wire News Releases
Thinking about buying stock in Advanced Micro Devices, General Electric, China Internet Nationwide, Spark Therapeutics or Titan Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for AMD, CIFS, GE, ONCE, and TTNP. 
From PR Newswire
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Spark Therapeutics, Inc. (ONCE) on Behalf of Stockholders and Encourages ONCE Investors to Contact the Firm
Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Spark Therapeutics, Inc. (NASDAQ: ONCE) on behalf of stockholders concerning the proposed acquisition of... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Spark Therapeutics, Inc. to Roche is Fair to Shareholders
To: All Persons or Entities who purchased Spark Therapeutics, Inc. (“Spark” or the “Company”) (NASDAQGS: ONCE) stock prior to February 25, 2019. 
From GlobeNewswire News Releases
Spark Therapeutics Enters into Definitive Merger Agreement with Roche
Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that it has entered into a... 
From GlobeNewswire News Releases
New Research Coverage Highlights General Electric, Redfin, Splunk, Spark Therapeutics, Innospec, and Hemispherx BioPharma — Consolidated Revenues, Company Growth, and Expectations for 2019
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of General Electric Company... 
From GlobeNewswire News Releases
Spark Therapeutics Reports 2018 Financial Results and Recent Business Progress
Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, announced today corporate and financial results for... 
From GlobeNewswire News Releases
Spark Therapeutics to Host Conference Call on Tuesday, Feb. 19 at 8:30 a.m. ET to Discuss 2018 Results and Recent Business Highlights
Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, will host a conference call on Tuesday, Feb. 19,... 
From GlobeNewswire News Releases
Spark Therapeutics Announces Presentation of Preclinical Data in Pompe Disease and CLN2 Disease at 15th Annual WORLDSymposium™
Spark Therapeutics (NASDAQ:ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, announced today the presentation of preclinical data... 
From GlobeNewswire News Releases
Rob Perez Joins General Atlantic as Operating Partner to Bolster Life Sciences Practice
General Atlantic, a leading global growth equity firm, announced today that Rob Perez, former President and CEO of Cubist Pharmaceuticals, Inc. has joined the firm as an Operating Partner. Based in the... 
From Business Wire News Releases
Spark Therapeutics to Participate in J.P. Morgan Healthcare Conference
Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that Jeffrey D. Marrazzo, chief... 
From GlobeNewswire News Releases
Spark Therapeutics Announces Updated Data on SPK-8011 from Ongoing Phase 1/2 Dose-escalation Clinical Trial in Hemophilia A at 60th American Society of Hematology (ASH) Annual Meeting and Exposition
Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, today announced updated preliminary data on the... 
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.